Cognos Therapeutics
Cognos Therapeutics is a high technology medical technology company specializing in innovative drug delivery solutions. Their flagship product, SINNAIS™, is a fully implantable drug delivery pump that features an AI-enabled feedback loop for localized drug administration, effectively addressing the challenge of bypassing the blood-brain barrier for conditions like Alzheimer’s disease and brain cancers. Cognos operates on a licensing and partnering model, targeting drug delivery challenges in hard-to-reach areas of the body and supporting disease models requiring continuous, long-term drug administration. With a focus on improving patient outcomes through advanced technology, Cognos is positioned to capture significant opportunities in the healthcare market.
Cognos Therapeutics
Cognos Therapeutics is a high technology medical technology company specializing in innovative drug delivery solutions. Their flagship product, SINNAIS™, is a fully implantable drug delivery pump that features an AI-enabled feedback loop for localized drug administration, effectively addressing the challenge of bypassing the blood-brain barrier for conditions like Alzheimer’s disease and brain cancers. Cognos operates on a licensing and partnering model, targeting drug delivery challenges in hard-to-reach areas of the body and supporting disease models requiring continuous, long-term drug administration. With a focus on improving patient outcomes through advanced technology, Cognos is positioned to capture significant opportunities in the healthcare market.